Epilepsy, Alzheimer’s disease, osteoporosis, colorectal cancer and bacterial infections are the targets of the research awards from the Minnesota Partnership for Biotechnology and Medical Genomics in 2018. This marks the partnership’s 15th year of spearheading new scientific ideas from Minnesota to improve health care for Minnesotans. The state-funded grants for these team science proposals total just under $5 million.

The five teams will initiate collaborative two-year projects that could transform the treatment of diseases that affect Minnesotans. All projects are selected on the basis of quality science, relevance of the medical need of the topic and potential of commercialization. Each team includes investigators from Mayo Clinic and the University of Minnesota. Projects must be truly collaborative ─ something that could not be pursued by either institution alone.

Read Mayo Clinic news release.

###

Related content:

• Learn more about Mayo Clinic Research.
• Find research feature stories, videos and news on Discovery's Edge, Mayo Clinic's online research magazine.
• Read other news releases from Mayo Clinic.

Tags: About, Awards, basic science, Minnesota Partnership